Alvotech (ALVO) Other Working Capital Changes (2021 - 2026)
Alvotech (ALVO) posted Other Working Capital Changes of -$8.2 million for Q1 2026, down 245.43% on a QoQ basis from $5.6 million in Q4 2025, and down 120.16% year-over-year from $40.5 million in Q1 2025.
Alvotech (ALVO) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Alvotech's Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$8.2 million for Q1 2026.
- Quarterly Other Working Capital Changes fell 120.16% year-over-year to -$8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.7 million (up 20.48% YoY) and the FY2025 annual result came in at -$4.2 million, up 40.44% from the prior year.
- Other Working Capital Changes was -$8.2 million for Q1 2026 at Alvotech, down from $5.6 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $13.3 million in Q2 2023 and bottomed at -$22.8 million in Q2 2022.
- A 5-year average of -$2.9 million and a median of -$3.0 million in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes soared 158.14% — and 2025, when it slumped 137745.06%.
- Alvotech's Other Working Capital Changes stood at -$11.1 million in 2022, then grew by 25.82% to -$8.3 million in 2023, then slipped by 23.32% to -$10.2 million in 2024, then jumped by 155.01% to $5.6 million in 2025, then plunged by 245.43% to -$8.2 million in 2026.
- Business Quant data shows ALVO's Other Working Capital Changes at -$8.2 million in Q1 2026, $5.6 million in Q4 2025, and -$10.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.16 Mn |
| Mar 31, 2026 | -8.16 Mn |
| Mar 31, 2026 | -8.16 Mn |
| Dec 31, 2025 | 5.61 Mn |
| Dec 31, 2025 | 5.61 Mn |
| Dec 31, 2025 | 5.61 Mn |
| Sep 30, 2025 | -10.56 Mn |
| Sep 30, 2025 | -10.56 Mn |
| Sep 30, 2025 | -10.56 Mn |
| Jun 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | 4.41 Mn |
| Mar 31, 2025 | -3.71 Mn |
| Mar 31, 2025 | -3.71 Mn |
| Mar 31, 2025 | -3.71 Mn |
| Dec 31, 2024 | -10.20 Mn |
| Dec 31, 2024 | -10.20 Mn |
| Dec 31, 2024 | -10.20 Mn |
| Sep 30, 2024 | 7,669.00 |
| Sep 30, 2024 | 7,669.00 |